Industry investment in dementia research

Investment from industry, such as pharmaceutical and biotech companies, is critical for advancing our understanding of dementia and developing new treatments and therapies for those living with dementia. Investment from industry can help accelerate the pace of research and improve the chances of finding life-changing treatments for dementia.

Image Embed Share Info

Close
global health and research development spend industry

Translating Science into breakthroughs: the future of late-stage dementia clinical trials in the UK.

Image Embed Share Info

Close
uk business spend research and development

Business enterprise research and development, UK – Office for National Statistics (ons.gov.uk)

Image Embed Share Info

Close
industry spend

Strength and Opportunity 2017  The landscape of the medical technology, medical biotechnology, pharmaceutical and industrial biotechnology sectors in the UK; Office of Life Sciences and UK Trade and Investment.

Image Embed Share Info

Close
industry trials clinical spend funding

ARUK report: The Economic Value of Dementia Research.

Industry and non-industry sponsored dementia trials

Download Graph Image Embed Share Info

Close
Industry sponsored clinical trials

ARUK report: The Economic Value of Dementia Research.

Almost all phase 3 clinical trials in the UK are funded by industry

Download Graph Image Embed Share Info

Close
industry funding clinical trials phase 3

ARUK report: The Economic Value of Dementia Research.